News
Latest News | Chronos Therapeutics
Innovation Voucher secured from Innovate UK
Chronos receives a grant for £5,000 to support the investigation of novel formulation strategies for its lead compound RDC5.
Experienced research leader Dr Kevin Thompson joins as Director, Chronoscreen™
Dr Kevin Thompson, an experienced biotech executive in both screening and neuroscience, joins as Director, Chronoscreen™. Kevin has over 20 years’ experience of drug screening and pre-clinical to clinical development.
Chronos at Venturefest Oxford, 2014
Chronos CEO Dr Huw Jones presented and took part in the Life Sciences Innovation stream at Venturefest 2014 held in Oxford’s Said Business School.
Chronoscreen™ Collaboration Agreement Signed
Chronos signs a collaboration agreement with large pharmaceutical company for our proprietary Chronoscreen™ technology.